SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/E416FDB6A0F6244550A8AB293CF4A016DF8C7FB3B11F156D9BC395831C2ECE3B1D064F3A0E0BA30B3E79528CF5432C8B>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/E416FDB6A0F6244550A8AB293CF4A016DF8C7FB3B11F156D9BC395831C2ECE3B1D064F3A0E0BA30B3E79528CF5432C8B
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/E416FDB6A0F6244550A8AB293CF4A016DF8C7FB3B11F156D9BC395831C2ECE3B1D064F3A0E0BA30B3E79528CF5432C8B
http://www.w3.org/2000/01/rdf-schema#comment
"BAP1 immunohistochemistry has limited prognostic utility as a complement of CDKN2A (p16) fluorescence in situ hybridization in malignant pleural mesothelioma."
xsd:string
http://purl.uniprot.org/uniprot/#_9BBE57D0AA82E156A8C2925F5A3293880CDD5BB878D78EE77EE9E7C8D59D7CCB2CFC68522D21E8351988C8E11DEA09E4
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/E416FDB6A0F6244550A8AB293CF4A016DF8C7FB3B11F156D9BC395831C2ECE3B1D064F3A0E0BA30B3E79528CF5432C8B
http://purl.uniprot.org/uniprot/Q92560
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/E416FDB6A0F6244550A8AB293CF4A016DF8C7FB3B11F156D9BC395831C2ECE3B1D064F3A0E0BA30B3E79528CF5432C8B
http://purl.uniprot.org/uniprot/#_Q92560-mappedCitation-27771374
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/E416FDB6A0F6244550A8AB293CF4A016DF8C7FB3B11F156D9BC395831C2ECE3B1D064F3A0E0BA30B3E79528CF5432C8B